Qiagen NV reported $1.44B in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2024
argenx SE 43.15M 4.1M Jun/2025
Avita Medical AUD 45.98M 895K Dec/2024
Dianthus Therapeutics USD 1.33M 161K Jun/2025
Ionis Pharmaceuticals USD 1.42B 169.27M Jun/2025
IQVIA Holdings USD 15.49B 1.16B Jun/2025
Moderna USD 741M 4M Jun/2025
Organon & Co USD 8.9B 60M Jun/2025
Qiagen NV USD 1.44B 35.7M Jun/2025
Revvity USD 3.17B 17.91M Mar/2025
Tectonic Therapeutic USD 876K 115K Dec/2024
Viatris USD 14.76B 580.1M Jun/2025
Xeris Pharmaceuticals USD 257.22M 10.01M Jun/2025